Search Results
Sep 09, 2026, 08:00 ET DJI Hosts Filmmakers & Visionaries Session at Venice Production Bridge During the 83rd Venice International Film Festival
compromise to emotional depth or technical precision. Both films demonstrate the full capabilities of cinematic storytelling compressed into a pocketable form. At Venice, this private creative truth became a public industry question.Screening the Future: From Theory to PracticeThe session
More news about: DJI
Sep 09, 2026, 08:00 ET DJI Hosts Filmmakers & Visionaries Session at Venice Production Bridge During the 83rd Venice International Film Festival
compromise to emotional depth or technical precision. Both films demonstrate the full capabilities of cinematic storytelling compressed into a pocketable form. At Venice, this private creative truth became a public industry question.Screening the Future: From Theory to PracticeThe session
More news about: DJI
Sep 09, 2026, 08:00 ET BEYOND THE CANVAS: JEFF KOONS REIMAGINES TIME WITH HUBLOT
world-renowned artist Jeff Koons. A partnership made to take shape. Both Koons and Hublot operate on the same principle: transforming tension into form; contradiction into harmony; excess into precision. What appears playful is meticulously engineered. What feels effortless is the result of absolute
More news about: Hublot SA
Sep 09, 2026, 08:00 ET BEYOND THE CANVAS: JEFF KOONS REIMAGINES TIME WITH HUBLOT
world-renowned artist Jeff Koons. A partnership made to take shape. Both Koons and Hublot operate on the same principle: transforming tension into form; contradiction into harmony; excess into precision. What appears playful is meticulously engineered. What feels effortless is the result of absolute
More news about: Hublot SA
Sep 09, 2026, 08:00 ET JENSEITS DER LEINWAND: JEFF KOONS UND HUBLOT DENKEN DIE ZEIT NEU
können. Eine Partnerschaft, die einfach Gestalt annehmen musste. Schließlich arbeiten Koons und Hublot nach den gleichen Prinzipien: Spannung wird in Form verwandelt; Widerspruch in Harmonie; aus Übermaß wird Präzision. Was spielerisch wirkt, ist in Wahrheit akribisch durchdacht. Was mühelos erscheint,
More news about: Hublot SA
Sep 09, 2026, 08:00 ET MetaVia Announces Preclinical Findings Supporting Biological Rationale for DA-1726's Waist Circumference Reduction
risks and uncertainties described in MetaVia's filings with the Securities and Exchange Commission, including MetaVia's most recent Annual Report on Form 10-K. Forward-looking statements speak only as of the date when made. MetaVia does not assume any obligation to publicly update or revise any forward-looking
More news about: MetaVia Inc.
Sep 09, 2026, 08:00 ET CENTURY LITHIUM FILES MINE PLAN OF OPERATIONS FOR ANGEL ISLAND LITHIUM PROJECT IN NEVADA
factors set out herein. These risks include those described under the heading "Risk Factors" in the Company's most recent annual information form and its other public filings, copies of which can be under the Company's profile at www.sedarplus.ca.
More news about: Century Lithium Corp.
Sep 09, 2026, 07:30 ET Owl Autonomous Imaging Selected for Pentagon-Led DUTCH Award to Advance Uncooled Thermal Imaging
camera systems.Owl AI's KnightOwl HD™ platform is designed to deliver high-quality uncooled LWIR imaging with the low-power architecture, compact form factor and scalable manufacturing approach required by emerging autonomous and defense systems."We are excited to support
More news about: Owl Autonomous Imaging
Sep 09, 2026, 07:30 ET Galmed Pharmaceuticals Becomes EoCene, Unveiling New Ticker Symbol "EOCN" to Reflect its New Dawn Platform for GI Innovation
Annual Report on Form 20-F for the year ended December 31, 2025, filed with the SEC on March 31, 2026 in greater detail under the heading "Risk Factors" and the additional risk factors relating to the business of Colospan Ltd. in the section entitled "Risk Factors" in our Report on Form 6-K filed with
More news about: Galmed Pharmaceuticals Ltd.
Sep 09, 2026, 07:30 ET Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer
and are subject to risks and uncertainties that could cause actual results to differ materially, including those described in Kazia's Annual Report on Form 20-F and subsequent filings with the SEC. Kazia undertakes no obligation to update any forward-looking statement except as required by law.
More news about: Kazia Therapeutics Limited
Sep 09, 2026, 07:27 ET Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference
future performance. These risks and uncertainties and other factors include the risks and uncertainties referred to in the Company's Annual Information Form filed with the Canadian securities administrators and U.S. Securities and Exchange Commission on March 31, 2026, available on SEDAR+ at sedarplus.ca
More news about: Cardiol Therapeutics Inc.
Sep 09, 2026, 07:05 ET Recent Stanton graduate wins Humane Science Award from National Anti-Vivisection Society
and put into practice. Alwakeel's passion for accelerating treatment options is personal, motivated by a family member's diagnosis with an aggressive form of breast cancer. He believes new tools, especially data-driven approaches, can help researchers ask better questions and pursue answers more efficiently
More news about: National Anti-Vivisection Society
Sep 09, 2026, 07:05 ET Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business
the industry, epidemics, pandemics or other public health crises, and other risks as set out under "Risk Factors" contained in the Annual Information Form dated June 10, 2026 (the "2026 AIF"). Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking
More news about: Aurora Cannabis Inc.
Sep 09, 2026, 07:00 ET Corteva, Globachem Enter into Definitive Agreement to Form a Joint Venture to Advance Development, Commercialization of New Formulated Crop Protection Solutions
forward-looking statements or other estimates is included in the "Risk Factors" section of Corteva's Annual Report on Form 10-K, and as modified by subsequent reports on Form 10-Q and Current Reports on Form 8-K.
More news about: Corteva Agriscience
Sep 09, 2026, 07:00 ET VIP Play, Inc. Furnishes Investor Presentation for Use in Initial Non-Deal Roadshow
factors that could cause actual results to differ materially, see the Company's filings with the SEC, including its Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q.About VIP Play, Inc.VIP Play, Inc. (OTCQB: VIPZ) is an AI-powered sports engagement company that helps
More news about: VIP Play, Inc.
Sep 09, 2026, 07:00 ET Z Squared Acquires Energized Arkansas Campus to Advance AI Infrastructure Strategy
reporting; and the other risks and uncertainties described under "Risk Factors" in the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, its Registration Statement on Form S-1 (File No. 333-296653) and its other filings with the U.S. Securities and Exchange Commission (Commission File
More news about: Z Squared Inc.
Sep 09, 2026, 07:00 ET Eltek Ltd. Announces CEO Transition: Retirement of Eli Yaffe and Appointment of Ron Freund as the Company's CEO
products and pricing, market acceptance, the sales cycle, changing economic conditions and other risk factors detailed in the Company's Annual Report on Form 20-F and other filings with the United States Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak
More news about: Eltek Ltd.
Sep 09, 2026, 07:00 ET DENARIUS METALS ANNOUNCES 7 KM EXTENSION OF PROPERTY HOLDINGS AT ITS TORAL PROJECT IN NORTHERN SPAIN, INCLUDING THE FORMER PRODUCING ZN-PB ANTONINA MINE; ALSO ANNOUNCES MAIDEN NI 43-101 MINERAL RESOURCE ESTIMATE FOR THE TORAL PROJECT
materially from those anticipated in these forward-looking statements are described under the caption "Risk Factors" in the Company's Annual Information Form dated March 31, 2026 which is available for view on SEDAR+ at
More news about: Denarius Metals Corp.
Sep 09, 2026, 07:00 ET Tyra Biosciences Reports Initial Phase 2 SURF302 Results Supporting the First Potential Oral Innovation in LG IR NMIBC with Dabogratinib
obtain regulatory approval for dabogratinib; and the other risks and uncertainties described under the heading "Risk Factors" in TYRA's Annual Report on Form 10-K and in subsequent filings with the Securities and Exchange Commission.You should not place undue reliance on these forward-looking statements,
More news about: Tyra Biosciences
Sep 09, 2026, 07:00 ET OceanaGold Submits Permit Application and Provides Technical and Exploration Update Supporting Mine Life Extension at Macraes
other factors identified and described in more detail in the section entitled "Risk Factors" contained in the Company's most recent Annual Information Form and the Company's other filings with Canadian securities regulators and the U.S. Securities and Exchange Commission (the "SEC"), which are available
More news about: OceanaGold Corporation
Sep 09, 2026, 07:00 ET OceanaGold Submits Permit Application and Provides Technical and Exploration Update Supporting Mine Life Extension at Macraes
other factors identified and described in more detail in the section entitled "Risk Factors" contained in the Company's most recent Annual Information Form and the Company's other filings with Canadian securities regulators and the U.S. Securities and Exchange Commission (the "SEC"), which are available
More news about: OceanaGold Corporation
Sep 09, 2026, 06:59 ET Bring ultrawide displays to the dashboard with Garmin Drive GPS navigators
including, but not limited to, the risk factors listed in the Annual Report on Form 10-K for the year ended December 27, 2025, filed by Garmin with the Securities and Exchange Commission (Commission file number 0-31983). Copies of such Form 10-K are available at
More news about: Garmin International, Inc.
Sep 09, 2026, 06:49 ET Centrus and Radiant Announce Long-Term Partnership for Domestic HALEU to Supply Kaleidos Microreactors
including our Annual Report on Form 10-K for the year ended December 31, 2025, under Part II, Item 1A - "Risk Factors" in our Quarterly report on Form 10-Q for the quarter ended March 31, 2026, under Part II, Item 1A - "Risk Factors" in our Quarterly report on Form 10-Q for the quarter ended
More news about: Centrus Energy Corp.
Sep 09, 2026, 06:33 ET Robo.ai Announces Proposed Establishment of Alif Maritec, a Marine Security and Intelligent Maritime Infrastructure Company
Alif Maritec will form part of Robo.ai's broader intelligent infrastructure platform. Once established, it will focus on four areas: maritime protection, smart ports, underwater
More news about: Alif Holding; Robo.ai Inc.
Sep 09, 2026, 06:30 ET Health In Tech Named to Newsweek's America's Greatest Mid-Market Companies 2026
common stock; and other risks and uncertainties described in the "Risk Factors" section of our most recent Annual Report on Form 10-K and our subsequent Quarterly Reports on Form 10-Q and other filings with the U.S. Securities and Exchange Commission.Any forward-looking statement made in this press
More news about: Health In Tech, Inc.